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E-cigarettes are gaining popularity in the U.S. as well as in other global markets. Currently, limited
published analytical data characterizing e-cigarette formulations (e-liquids) and aerosols exist. While
FDA has not published a harmful and potentially harmful constituent (HPHC) list for e-cigarettes, the
HPHC list for currently regulated tobacco products may be useful to analytically characterize e-cigarette
aerosols. For example, most e-cigarette formulations contain propylene glycol and glycerin, which may
produce aldehydes when heated. In addition, nicotine-related chemicals have been previously reported
as potential e-cigarette formulation impurities. This study determined e-liquid formulation impurities
and potentially harmful chemicals in aerosols of select commercial MarkTen® e-cigarettes manufactured
by NuMark LLC. The potential hazard of the identiﬁed formulation impurities and aerosol chemicals was
also estimated. E-cigarettes were machine puffed (4-s duration, 55-mL volume, 30-s intervals) to battery
exhaustion to maximize aerosol collection. Aerosols analyzed for carbonyls were collected in 20-puff
increments to account for analyte instability. Tobacco speciﬁc nitrosamines were measured at levels
observed in pharmaceutical grade nicotine. Nicotine-related impurities in the e-cigarette formulations
were below the identiﬁcation and qualiﬁcation thresholds proposed in ICH Guideline Q3B(R2). Levels of
potentially harmful chemicals detected in the aerosols were determined to be below published occu-
pational exposure limits.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The U.S. Food and Drug Administration (FDA) recently estab-
lished a list of harmful and potentially harmful constituents
(HPHCs) for currently regulated tobacco products (e.g., cigarettes)
(FDA, 2012a). FDA guidance deﬁned harmful and potentially
harmful constituents as “any chemical or chemical compound in a
tobacco product or in tobacco smoke: a) that is or potentially is
inhaled, ingested, or absorbed into the body; and b) that causes or
has the potential to cause direct or indirect harm to users or non-
users of tobacco products” (FDA, 2011). Subsequently, a list of
more than 90 HPHCs was communicated (FDA, 2012a).
However, there is a lack of in-house laboratory capabilities, a
potential for large and unmanageable testing volumes in contract615 Maury Street, Richmond,
iencePublications@altria.com
Inc. This is an open access article ulaboratories, and a lack of validated analytical test methods for all of
the HPHCs listed on the established list (FDA, 2012a). Therefore,
FDA published an abbreviated HPHC list for initial regulatory
reporting requirements (FDA, 2012b). The abbreviated list com-
prises constituents for which analytical methods were thought to
be established and which represent several different chemical
classes. Table 1 shows the abbreviated list of HPHCs that are initially
required by FDA to be reported for cigarette smoke and cigarette
ﬁller (i.e., tobacco that is a component of a cigarette).
FDA requires reporting the quantities of all HPHCs on the
abbreviated list for a regulated tobacco product. Currently, the
regulated tobacco products that require HPHC reporting are ciga-
rettes (smoke and tobacco ﬁller), smokeless tobacco, and roll-your-
own tobacco.
E-cigarettes, also referred to as electronic nicotine delivery
systems or e-vapor products, are gaining popularity in the U.S and
other global markets. FDA (2014) published a proposed deeming
rule that would extend the agency's regulatory authority to include
e-cigarettes; at this time inmanuscript preparation (June 2015), thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Abbreviations
ACGIH American Conference of Governmental Industrial
Hygienists
B[a]P benzo[a]pyrene
BLOQ below the limit of quantitation
CFP Cambridge ﬁlter pads
CO carbon monoxide
CORESTACooperation Centre for Scientiﬁc Research Relative to
Tobacco
CRM CORESTA-recommended method
DFG Deutsche Forschungsgemeinschaft
DNPH 2,4-dinitrophenylhydrazine
EPA U.S. Environmental Protection Agency
FDA U.S. Food and Drug Administration
GC gas chromatography
GC-MS gas chromatography-mass spectrometry
HCI Health Canada Intense
HPHC harmful and potentially harmful constituent
IC-CD ion chromatography with a conductivity detector
ICP-MS inductively coupled plasma mass spectrometry
ICH International Conference on Harmonisation
ISO International Organization for Standardization
LC-MS/MS liquid chromatography-tandem mass spectrometry
LOD limit of detection
LOQ limit of quantitation
MDPH Massachusetts Department of Public Health
MS/MS tandem mass spectroscopy
NIOSH National Institute of Occupational Safety and Health
NNK 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
NNN N-nitrosonornicotine
NSRL No Signiﬁcant Risk Level
OEHHA Ofﬁce of Environmental Health Hazard Assessment
OSHA Occupational Health and Safety Administration
PEL permissible exposure limit
RfC reference concentration
SIM selected ion monitoring
SPE solid-phase extraction
TLV threshold limit value
TSNA tobacco speciﬁc nitrosamine
TWA time-weighted average
UPLC-MS/MS ultra performance liquid chromatography-
tandem mass spectrometry
UV ultraviolet
VOC volatile organic compound
WHO World Health Organization
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available in both disposable and rechargeable formats. The
rechargeable devices have either a reﬁllable or disposable cartridge.
When a user puffs on an e-cigarette, a liquid is heated, aerosolized,
and inhaled. E-cigarette formulations (often called e-liquids) typi-
cally contain propylene glycol and/or glycerin, water, nicotine, and
ﬂavors.
The number of publications focusing on the chemical charac-
terization of e-cigarette formulations and aerosols is increasing.
Most studies seek to identify impurities in the formulation such as
tobacco speciﬁc nitrosamines (TSNAs) and nicotine-related impu-
rities (Cobb et al., 2010; Trehy et al., 2011; Westenberger, 2009),
while other studies focus on identifying potentially harmful
chemicals in the aerosol such as carbonyl compounds, volatile
organic compounds (VOCs), TSNAs, metals, and silicates (Goniewicz
et al., 2014; Tayyarah and Long, 2014; Williams et al., 2013).Table 1
Abbreviated list of HPHCs in cigarette smoke and cigarette ﬁller (FDA, 2012b).
HPHCs in cigarette smoke HPHCs in cigarette ﬁller
Acetaldehyde Ammonia
Acrolein Arsenic
Acrylonitrile Cadmium
4-Aminobiphenyl Nicotine (total)
1-Aminonaphthalene NNK
2-Aminonaphthalene NNN
Ammonia
Benzene
Benzo[a]pyrene
1,3-Butadiene
Carbon monoxide
Crotonaldehyde
Formaldehyde
Isoprene
Nicotine (total)
NNK
NNN
Toluene
HPHC, harmful and potentially harmful constituents; NNK, 4-(methylnitrosamino)-
1-(3-pyridyl)-1-butanone; NNN, N-nitrosonornicotine.Additionally, a recent study investigated the impact of design pa-
rameters such as battery output voltage on the generation of
potentially harmful chemicals such as carbonyl compounds in the
e-cigarette aerosol (Kosmider et al., 2014).
One of the objectives of this research was to determine and
quantify potential impurities and degradation products in the for-
mulations and aerosols of four e-cigarettes (rechargeable with
disposable cartridges) manufactured by Nu Mark LLC, an Altria
company, and sold asMarkTen®. The other objectivewas to conduct
a risk assessment analysis of these e-liquid formulation impurities
and aerosol chemicals. Because the regulation of e-cigarettes has
not yet been promulgated and no speciﬁc HPHC list exists for e-
cigarette formulations and aerosols, this study focused on
measuring chemicals that are listed for cigarette tobacco and
smoke on the abbreviated HPHC list published by FDA (2012b)
(Table 1) as well as chemicals identiﬁed in publications focused
on analytical characterization of e-cigarette liquid formulations and
aerosols (Cheng, 2014; Cobb et al., 2010; Etter et al., 2013; FDA,
2012b; Goniewicz et al., 2014; Kosmider et al., 2014; Tayyarah
and Long, 2014; Trehy et al., 2011; Uchiyama et al., 2013;
Westenberger, 2009; Williams et al., 2013).2. Methods
2.1. E-cigarette test products
Four commercial e-cigarette products available in the U.S.
marketplace (at the time of manuscript preparation) produced by
Nu Mark LLC (an Altria company) under the MarkTen® brand name
were included in all analytical evaluations. The commercial prod-
ucts were the MarkTen® Menthol and Classic sold in Indiana and
Arizona during the ﬁrst quarter of 2014, and all contained 1.5%
nicotine by weight. The average nicotine delivery for these devices
was 29 mg/puff under the machine smoking conditions discussed
below and shown in Table 5 (4 s puffs, 55 mL puff volume, puffed in
20 puff increments to battery exhaustion).
J.W. Flora et al. / Regulatory Toxicology and Pharmacology 74 (2016) 1e11 32.2. Formulation analysis
All e-cigarette testing methodologies for formulation (e-liquids)
characterization were validated based upon the 2005 International
Conference on Harmonisation (ICH) guideline “Validation of
Analytical Procedures: Text and Methodology Q2(R1)” (ICH, 2005).
For chemicals listed on the abbreviated HPHC list (FDA, 2012b)
(Table 1), the validations were conducted for cigarette tobacco and
adapted for e-cigarette formulations following details provided
herein. In the interest of reproducibility, CORESTA (Cooperation
Centre for Scientiﬁc Research Relative to Tobacco) recommended
methods (CRMs) were applied (Table 2) when available. For spec-
iﬁed nicotine impurities, methods were developed and validated
speciﬁcally for e-cigarette formulations. Unless speciﬁed otherwise,
the limits of quantitation (LOQ) are based on the lowest calibration
standards, and the limits of detection (LOD) are estimated based
upon a signal-to-noise ratio of 3. LOQs and LODs are described
throughout on a per gram basis of the e-cigarette formulations.
Nicotine was not included in the analysis as it is added to e-ciga-
rette formulations in known quantities and is, therefore, neither an
impurity nor a degradation product. Chemical class, analyte,
instrumentation, and method summaries are listed in Table 2;
analytical details are provided in Sections 2.2.1 through 2.2.4.
2.2.1. Arsenic and cadmium in e-cigarette formulations
This method was developed to quantitatively determine the
amounts of arsenic and cadmium in tobacco cigarette ﬁller using
inductively coupled plasma mass spectrometry (ICP-MS). The LOQs
for arsenic and cadmium were 430 and 220 ng/g of formulation,
respectively. Analysis was conducted by Arista Laboratories (Rich-
mond, VA), and LODs were not available.
2.2.2. TSNAs in e-cigarette formulations
This method was developed and validated to quantitatively
determine the concentration of TSNAs in tobacco and tobacco
products using liquid chromatography with tandem mass spec-
trometry (LC-MS/MS). The TSNAs analyzed with this method were
N-nitrosonornicotine (NNN; CAS #16543-55-8) and 4-(methylni-
trosamino)-1-(3-pyridyl)-1-butanone (NNK; #CAS 64091-91-4).
TSNA standards were purchased from Spex Certiprep (Metuchen,
NJ), and isotopically labeled internal standards were purchased
from Toronto Research Chemicals (Ontario, Canada). All other high-
purity chemicals and reagents were purchased from Fisher Scien-
tiﬁc (Pittsburgh, PA). The method of analysis followed CRM No 72
(CORESTA, 2013a). The method was adapted for e-cigarette liquidsTable 2
Summary of analytical methodologies used for e-cigarette formulation analysis.
Chemical class Analyte Instr
Metals Arsenic ICP-M
Cadmium
Tobacco speciﬁc nitrosamines NNK LC-M
NNN
Ammonia Ammonia IC-CD
Nicotine-related impurities Nicotine-N-oxides LC-M
Cotinine
Nornicotine
Anatabine
Myosmine
Anabasine
b-Nicotyrine
CRM, CORESTA-recommended method; IC-CD, ion chromatography with conductivity d
chromatography-tandem mass spectrometry; NNK, 4-(methylnitrosamino)-1-(3-pyridyl
a Arista Laboratories (Richmond, VA).
b CRM No 72 (see CORESTA, 2013a).
c CRM No 73 (see CORESTA, 2011).by adding 0.45 g formulation to 10 mL 100 mM ammonium acetate
extraction solution prior to analysis. The LOQ for both NNN and
NNK was 90.0 ng/g, and the estimated LODs were 0.71 and 0.92 ng/
g, respectively.
2.2.3. Ammonia in e-cigarette formulations
This method was developed and validated to quantitatively
determine the content of ammonia in tobacco products (cigarette
ﬁller, pouched snus smokeless tobacco, moist smokeless tobacco,
loose dry snuff smokeless tobacco, and loose leaf chewing tobacco)
by ion chromatography with a conductivity detector (IC-CD). The
method was adapted for e-cigarette liquids from CRM No 73
(CORESTA, 2011) by adding 0.25 g formulation to 100 mL extraction
solution (0.025 N sulfuric acid) prior to analysis. Chemicals and
reagents were purchased from Fisher Scientiﬁc (Pittsburgh, PA).
The LOQ was 40 mg/g, and the estimated LOD was 2.0 mg/g.
2.2.4. Nicotine-related impurities in e-cigarette formulations
This method was developed and validated to quantitatively
determine the amounts of nicotine-N-oxides (cis and trans; CAS
#491-26-9), cotinine (CAS #486-56-6), nornicotine (CAS #5746-86-
1), anatabine (CAS #2743-90-0), myosmine (CAS #532-12-7), ana-
basine (CAS #13078-04-1), and b-nicotyrine (CAS #487-19-4) in e-
cigarette formulations using LC-MS/MS. As these analytes are not
included in the abbreviated HPHC list and are not routinely
measured in tobacco products, additional details are provided for
this method. All nicotine-related impurities and internal standards
were purchased from Toronto Research Chemicals Inc. (Toronto,
Ontario, Canada). It should be noted that some nicotine impurities
such as nicotine-N-oxides are known to be thermally unstable
which prevented the use of gas chromatography (GC) for this
analysis. Calibration standards ranged from 0.10 mg/mL to 5.0 mg/mL
with a coefﬁcient of determination greater than 0.9989. Prior to
analysis, e-cigarette cartridges were disassembled and all compo-
nents, including gauze, heater coil assembly, and metal shell, were
placed in 20-mL glass vials. An extraction solution (10 mL of 70:30,
methanol:water) was added containing the deuterated internal
standards (2.0 mg/mL) listed in Table 3. Vials were then capped and
vortexed for 30 min using a Glas-Col (Terre Haute, IN) vortexer at
70% motor speed. Aliquots of the extraction solution were then
transferred to auto sampler vials, and 1 mL was injected on the
ultra-performance liquid chromatograph coupled to tandem mass
spectrometry (UPLC-MS/MS) instrumentation.
Liquid chromatography was conducted on a Waters ACQUITY®
UPLC instrument (Milford, MA) with a Waters ACQUITY® X-Bridgeumentation Method summary
S Formulation analyzed by Aristaa
S/MS CRM No 72b (0.45 g formulation in 10 mL)
CRM No 73c (0.25 g of formulation in 100 mL)
S/MS Internal method; whole cartridge extraction (10 mL)
etector; ICP-MS, inductively coupled plasma mass spectrometry; LC-MS/MS, liquid
)-1-butanone; NNN, N-nitrosonornicotine.
Table 3
Speciﬁed nicotine impurities and labeled internal standards used
for analyte quantitation (Council of Europe, 2012).
Analyte Internal standard
Myosmine Myosmine-d4
Nornicotine Nornicotine-d4
b-Nicotyrine Myosmine-d4
Anatabine Myosmine-d4
Anabasine Anabasine-d4
Cotinine Cotinine-d3
Nicotine-N-oxide Cotinine-d3
Table 5
Smoking machine puff proﬁle settings.
Parameter Setting
Square wave Uniform air transfer throughout puff duration
Volumetric air ﬂow 825 mL/min
Puff volume 55.0 ± 0.3 mL
Puff duration 4.00 ± 0.02 s
Puff interval 30.0 ± 0.5 s
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wash solvent were 10 mM ammonium acetate (pH 10), and mobile
phase B and the strong wash solvent were Optima™ grade meth-
anol (Fisher Scientiﬁc, Pittsburgh, PA). Sample temperature was
held at 15 C, and column temperature was at ambient conditions.
UPLC mobile phase ﬂow rate was set to 0.3 mL/min. The nicotine
impurities were detected by tandemmass spectroscopy (MS/MS) in
the UPLC eluent using multiple reaction monitoring. The LOQ for all
speciﬁed impurities was 4.8 mg/g, and the estimated LODs ranged
from 0.025 to 0.39 mg/g.2.3. Aerosol analysis
All testing methodologies for aerosol characterization were
validated based upon the 2005 ICH guideline “Validation of
Analytical Procedures: Text and Methodology Q2(R1)” (ICH, 2005).
For potential impurities listed on the abbreviated HPHC list (FDA,
2012b) (Table 1) (excluding aerosol nicotine), the validations
were conducted for cigarette smoke and adapted for e-cigarette
aerosols following details provided herein. In the interest of
reproducibility, CRMs and/or International Organization for Stan-
dardization (ISO) standards were applied (Table 4) when available.Table 4
Summary of analytical methodologies used for e-cigarette aerosol analysis.
Chemical class Analyte Smoking machine; aerosol collection
Carbonyls Acetaldehyde KC Automation 5-port linear; 5 sets
Acrolein
Crotonaldehyde
Formaldehyde
Aromatic amines 4-Aminobiphenyl Cerulean 20-port linear; 100 puffs or
1-
Aminonaphthalene
2-
Aminonaphthalene
Volatile organic compounds Acrylonitrile KC Automation 5-port linear; 100 pu
exhaustionBenzene
1,3-Butadiene
Isoprene
Toluene
Tobacco speciﬁc
nitrosamines
NNK KC Automation 5-port linear; 100 pu
exhaustionNNN
Ammonia Ammonia Cerulean 20 port linear; 100 puffs or
Polyaromatic hydrocarbons Benzo[a]pyrene Cerulean 20 port linear; 100 puffs or
Carbon monoxide Carbon monoxide Cerulean 20 port linear; 2 sets of 50
CRM, CORESTA-recommended method; GCeMS, gas chromatography-mass spectromet
ternational Organization for Standardization; LC-MS/MS, liquid chromatography-tandem
N-nitrosonornicotine; UPLC-UV, ultra-performance liquid chromatography with ultravio
aCRM No 74 (see CORESTA, 2014a).
bCRM No 70 (see CORESTA, 2013b).
cCRM No 75 (see CORESTA, 2012).
dCRM No 58 (see CORESTA, 2014b).
eISO 22634 (see ISO, 2008).
fCRM No 5 (see CORESTA, 1993).
gISO 8454 (see ISO, 2007).Unless speciﬁed otherwise, the LOQs are based on the lowest
calibration standards, and the LODs are estimated based upon a
signal-to-noise ratio of 3. Chemical class, analyte, instrumentation,
and method summaries are listed in Table 4; analytical details are
provided in Sections 2.3.2 through 2.3.9.
2.3.1. Aerosol collection
All aerosol collections were conducted under ISO smoking
environmental conditions (ISO, 2012) with temperature at
22.0 C ± 2.0 C and relative humidity at 60% ± 5%. The protocols for
aerosol collectionwere based upon the Health Canada Intense (HCI)
smoking regime (Health Canada, 1999) puff volume and puff in-
terval. However, a square wave puff proﬁle was needed to activate
the puff sensors, and ventilation blocking was not applicable to the
e-cigarette designs. The regime selected (Table 5) was slightly
greater than the average pufﬁng topography of experienced e-
cigarette users to the best of our knowledge at this time (Vansickel
et al., 2014). At the time of this research, the testing regime was
consistent with one of the regimes being evaluated by the CORESTA
E-Cigarette Task Force. A technical report from the CORESTA E-
Cigarette Task Force (2015) concluded, among other things, that
for the pufﬁng parameters evaluated, yields were similar, precision
was acceptable, and there was no technical advantage among the
pufﬁng parameters tested. All device batteries were fully charged
prior to aerosol collection.details Instrumentation; CRM/ISO standard
of 20 puffs UPLC-UV; CRM No 74a
battery exhaustion GCeMS; (Cambridge ﬁlter pad collection)
ffs or battery GCeMS; CRM No 70b
ffs or battery LC-MS/MS; CRM No 75c
battery exhaustion IC-CD; (2 impingers with acidic aqueous solution)
battery exhaustion GCeMS; (Cambridge ﬁlter pad collection) CRM No 58d /ISO
22634e
puffs CO analyzer (IR) with SM450; CRM No 5f/ISO 8454g
ry; IC-CD; ion chromatography with a conductivity detector; IR, infra-red; ISO, In-
mass spectrometry; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; NNN,
let absorbance detection.
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In all cases where Cambridge ﬁlter pads (CFP) were used, the CFP
was 44 mm with one exception: benzo[a]pyrene (B[a]P) collection
used a 92-mm CFP. In most cases, in the interest of increasing
method sensitivity, e-cigarette devices were puffed to battery
exhaustion (where the device no longer activated), and the total
collected aerosol was analyzed. With the 4-s puff duration, this was
approximately 80e100 puffs. However, for aerosol collection for the
determination of carbonyls, the devices were puffed in 20-puff
increments because the analytes in this chemical class are known
to be unstable. If carbonyls were collected with more puffs (e.g.,
approximately 100 puffs), it is highly likely that the values would be
underestimated on an estimated per puff basis due to analyte loss.
Carbon monoxide (CO) in e-cigarette aerosol was measured using a
gas-phase spectrographic technique (discussed in Section 2.3.8) for
50-puff collections.2.3.2. Carbonyls in e-cigarette aerosol
This method was developed and validated to quantitatively
determine the concentration of formaldehyde (CAS #50-00-0),
acetaldehyde (CAS #75-07-0), acrolein (CAS #107-02-8), and cro-
tonaldehyde (CAS #4170-30-3) (Supelco, Bellefonte, PA) in main-
stream cigarette smoke. The method of analysis was adapted for e-
cigarette aerosol from CRM No 74 (CORESTA, 2014a) for cigarette
smoke analysis by implementation of the aerosol collection dis-
cussed in Section 2.3.1 and the following procedure. E-cigarette
aerosol was collected on a 5-port linear Borgwaldt, KC Automation
(Richmond, VA) smoking machine using two impingers containing
30 mL of 2,4-dinitrophenylhydrazine (DNPH) (Aldrich Chemical
Company, Milwaukee, WI) and perchloric acid in acetonitrile
(Fisher Scientiﬁc, Atlanta, GA). The aerosol extracts were analyzed
for the respective hydrazones using UPLC (Waters ACQUITY®) with
ultraviolet/visible (UPLC-UV) absorbance detection. For carbonyl
analysis, samples were collected for 20-puff intervals until the
battery was exhausted (approximately ﬁve collections). The LOQs
and LODs were, respectively, 0.71 and 0.079 mg/puff for acetalde-
hyde, 0.36 and 0.09 mg/puff for acrolein, 0.19 and 0.080 mg/puff for
crotonaldehyde, and 0.036 and 0.013 mg/puff for formaldehyde. As
formaldehyde has been detected in background samples due to
contamination from the environment and DNPH, all formaldehyde
levels reported here have been corrected by subtracting the average
concentration of formaldehyde in the blank samples that were
collected and analyzed during the same time as the e-cigarette
samples (0.18 mg/puff collection).2.3.3. Aromatic amines in e-cigarette aerosol
A GCeMS method was developed and validated to quantita-
tively determine the concentration of 1-aminonaphthalene (CAS
#134-32-7), 2-aminonaphthalene (CAS #91-59-8), and 4-
aminobiphenyl (CAS #92-67-1) in mainstream cigarette smoke.
Standards were purchased from SigmaeAldrich (Milwaukee, WI)
and internal standards from CDN Isotopes (Quebec, Canada). The
method was adapted for e-cigarette aerosol by implementation of
the aerosol collection discussed in Section 2.3.1 and the following
procedure. E-cigarette aerosol was collected on a Cerulean (Milton
Keynes, UK) 20-port linear smoking machine onto a CFP. The CFP
was extracted with 5 mL hexanes. The extract was derivatized with
trimethylamine and pentaﬂuoropropionic anhydride (Fisher Sci-
entiﬁc, Pittsburgh, PA) and concentrated to 1 mL prior to GCeMS
analysis. The LOQs for 1-aminonaphthalene, 2- aminonaphthalene,
and 4-aminobiphenyl were 2.0, 1.0, and 0.50 ng/device, respectively
(when puffed to battery exhaustion), and the estimated LODs were
0.17, 0.099, 0.068 ng/device, respectively.2.3.4. Volatile organic compounds in e-cigarette aerosol
This method was developed and validated to quantitatively
determine the concentration of ﬁve VOCs including 1,3-butadiene
(CAS #106-99-0), isoprene (CAS #78-79-5), acrylonitrile (CAS
#107-13-1), benzene (CAS #71-43-2), and toluene (CAS #108-88-3)
in mainstream cigarette smoke. Custom standard and internal
standard stock solutions were commercially prepared by Restek
Corporation (Bellefonte, PA). The method was adapted for e-ciga-
rette aerosol from CRMNo 70 (CORESTA, 2013b) for cigarette smoke
analysis by implementation of the aerosol collection discussed in
Section 2.3.1 and the following procedure. E-cigarette aerosol was
collected on a 5-port KC Automation smoking machine after pass-
ing through a CFP followed by two chilled impinger traps (chilled
with 2-propanol and dry ice) containing methanol. The CFP was
extracted with the contents of the impingers. The resulting aerosol
extract was analyzed by GCeMS. The LOQs for 1,3-butadiene,
isoprene, acrylonitrile, benzene, and toluene were 10, 50, 5.0, 10,
and 20 mg/device, respectively (when puffed to battery exhaustion).
The estimated LODs were 3.4, 3.3, 3.3, 1.2, and 1.7 mg/device,
respectively.
2.3.5. Tobacco speciﬁc nitrosamines in e-cigarette aerosol
This method was developed and validated to quantitatively
determine the concentration of TSNAs in mainstream cigarette
smoke. The TSNAs determined with this method were NNN and
NNK. The method was adapted for e-cigarette aerosol from CRM No
75 (CORESTA, 2012) for cigarette smoke analysis by implementa-
tion of the aerosol collection discussed in Section 2.3.1. The TSNAs
were collected as described for VOCs in Section 2.3.4 on a CFP,
which was extracted with methanol and analyzed by LC-MS/MS.
The LOQ for both TSNAs was 40 ng/device (when puffed to bat-
tery exhaustion), and the estimated LODs for NNK and NNN were
0.41 and 0.31 ng/device, respectively.
2.3.6. Ammonia in e-cigarette aerosol
This method was developed and validated to quantitatively
determine the concentration of total ammonia in mainstream
cigarette smoke. Total ammoniawas deﬁned as ammonia present in
the particulate phase deposited on the CFP and ammonia in the gas
phase that is trapped by the impinger solution. The method was
adapted for e-cigarette aerosol by implementation of the aerosol
collection discussed in Section 2.3.1. Using a 20-port Cerulean
smoking machine, e-cigarette aerosol was collected on a CFP in
series with two impinger traps containing dilute acidic solution
(0.025 N sulfuric acid). After pufﬁng, the CFP was extractedwith the
impinger solution, converting ammonia to ammonium. The e-
cigarette aerosol extract was analyzed by IC-CD. The LOQwas 10 mg/
device (when puffed to battery exhaustion), and the estimated LOD
was 0.52 mg/device.
2.3.7. Benzo[a]pyrene in e-cigarette aerosol
This method was developed and validated to quantitatively
determine the amounts of B[a]P (CAS #50-32-8) in mainstream
cigarette smoke. The method of analysis was adapted for e-ciga-
rette aerosol from CRM No 58 (CORESTA, 2014b) and ISO standard
22634:2008 (ISO, 2008) for cigarette smoke analysis. The method
was adapted for e-cigarette aerosol by implementation of the
aerosol collection discussed in Section 2.3.1 and the following
procedure. B[a]P was purchased from SigmaeAldrich (St. Louis,
MO) and all other reagents were purchased from Fisher Scientiﬁc.
E-cigarette aerosol was collected on a CFP using a 20-port Cerulean
smokingmachine. The CFPwas extractedwith 5mL hexanes. The e-
cigarette aerosol extract was ﬁltered, re-constituted to 300 mL and
analyzed by GC/MS. The LOQ for B[a]P was 10 ng/device, and the
estimated LOD was 2.2 ng/device.
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CO in e-cigarette aerosols was measured following CRM No 5
(CORESTA, 1993) and ISO standard 8454:2007 (ISO, 2007) using a
CO analyzer (infrared) with a Cerulean SM450. LOQ was 5.0 mg/
device, and LOD was not determined.
2.3.9. Nicotine in e-cigarette aerosol
This method was developed and validated to quantitatively
determine the concentration of nicotine (purchased from Acros)
(CAS# 54-11-5) in e-cigarette aerosols. E-cigarette aerosol was
collected on a CFP in 20 puff increments using a 20-port Cerulean
smoking machine by implementation of the aerosol collection
discussed in Section 2.3.1. The CFP was extracted with 20 mL n-
propanol containing Quinoline (Arcos) as the internal standard and
rotated for 30 min. The e-cigarette aerosol extract was analyzed by
GC with a ﬂame ionization detector. The LOQ was 10 mg/puff and
LOD was not determined.
2.4. Toxicological evaluation e risk assessment
Quantitative risk assessment calculations were performed for all
listed potential impurities and degradation products for which
there were published exposure limits as established by U.S. Envi-
ronmental Protection Agency (EPA) in the Integrated Risk Infor-
mation System (IRIS), California Ofﬁce of Environmental Health
Hazard Assessment (OEHHA; Proposition 65), American Confer-
ence of Governmental Industrial Hygienists (ACGIH), Occupational
Safety and Health Administration (OSHA), or Deutsche For-
schungsgemeinschaft (DFG) (Table 6). Proposition 65 lists No Sig-
niﬁcant Risk Levels (NSRLs), which are deﬁned as daily intake levels
posing a 105 (i.e., 1 in 100,000) lifetime risk of cancer (OEHHA,
2013). EPA provides carcinogenic inhalation concentrations at
speciﬁed risk levels (e.g., 104,105,106). These values provide risk
assessors with daily exposure levels of chemicals below which no
additional signiﬁcant toxicological risk may be incurred in a pop-
ulation. For the calculations made in this assessment, EPA exposure
values corresponding with a 1 in 1 million (106) lifetime increasedTable 6
Risk assessment values.
Chemical class Analyte IRISa (mg/m3) NSRLb (mg/day)
Carbonyls Acetaldehyde 0.5 90
Acrolein N/A N/A
Crotonaldehyde N/A N/A
Formaldehyde 0.08 40
Aromatic amines 4-Aminobiphenyl N/A 0.03
Volatile organic compounds Acrylonitrile 0.01 0.07
Benzene 0.13 13
1,3-Butadiene 0.03 0.4
Isoprene N/A N/A
Toluene N/A 13,000
Tobacco speciﬁc nitrosamines NNK N/A 0.014
NNN N/A 0.5
Ammonia Ammonia N/A N/A
Polyaromatic hydrocarbons Benzo[a]pyrene N/A 0.06
Carbon monoxide Carbon monoxide N/A N/A
Metals Arsenic 0.0002 0.06
Cadmium 0.0006 0.05
DFG, Deutsche Forschungsgemeinschaft; IRIS, Integrated Risk Information System; N/A,
(methylnitrosamino)-1-(3-pyridyl)-1-butanone; NNN, N-nitrosonornicotine; NSRL, no s
TLV, threshold limit value.
a As reported by EPA (1998a, 1998b, 1998c, 2002, 2003a, 2003b, 2003c).
b As reported by OEHHA (2013) (Toluene is a maximum allowable daily limit).
c As reported by ACGIH (2015).
d As reported by OSHA (2003).
e As reported by EPA ( 1998b, 2002, 2003a, 2003b, 2003d, 2003e, 2005).cancer risk were used. Additionally, EPA may also provide a refer-
ence concentration (RfC), which is an estimate of a continuous
inhalation exposure to humans that is likely to be without an
appreciable risk of deleterious (non-cancer) effects during a life-
time. In general, threshold limit values (TLVs) and maximum
allowable concentrations provided by ACGIH, OSHA, and/or DFG
specify the limiting exposure concentrations of chemicals for daily
inhalation during an 8-h workday over the course of a working
lifetime. These levels are based upon an expert review of the
published scientiﬁc literature in the areas of medicine, toxicology,
industrial hygiene, and epidemiology. These values represent a
level of exposure that a typical healthy worker can experience
repeatedly without adverse health effects. Using TLVs, the daily
exposure to a chemical without expected adverse health effects can
be calculated by using the time-weighted average for 8 h/day
(TWA-8 h) and assuming a daily air inhalation rate of 28.8 m3/day
or 1.2 m3/h. For e-cigarette liquid formulations, a conservative
transfer rate of 100% was assumed.
The following is an example using the TLV TWA-8 h for arsenic
and its salts as arsenic. The TWA is reported as 0.01 mg/m3 (ACGIH,
2015). Equation (1) is used to convert the TWA to an equivalent
daily exposure:
exposureconcentration

mg
m3

hourlyinhalationrate

m3
h

 lengthof workday

8h
day

¼estimateddailyexposure

mg
day

(1)
Such that,
0:01mg
m3
 1:2m
3
h
 8h
day
¼ 0:096 mg
day
¼ 96 mg
day
To compare the equivalent daily exposure derived fromTLVc (mg/m3) PELd (mg/m3) RfCe (mg/m3) DFGc (mg/m3) NIOSHc (mg/m3)
N/A 360 0.009 91 N/A
N/A 0.25 0.00002 N/A 0.25
N/A 6 N/A N/A N/A
N/A N/A N/A 0.37 N/A
N/A N/A N/A N/A N/A
4.3 N/A 0.002 N/A N/A
1.6 3 0.03 N/A N/A
4.4 2.2 0.002 N/A N/A
N/A N/A N/A 8.5 N/A
75 N/A 5 190 375
N/A N/A N/A N/A N/A
N/A N/A N/A N/A N/A
17 35 0.1 14 18
N/A 0.2 N/A N/A 0.1
29 55 N/A 35 40
0.01 0.01 N/A N/A N/A
N/A 0.005 N/A N/A N/A
not available; NIOSH, National Institute of Occupational Safety and Health; NNK, 4-
igniﬁcant risk level; PEL, permissible exposure limit; RfC, reference concentration;
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from the e-cigarette using the arsenic LOQ assuming 100% transfer
from e-liquid formulation to aerosol, Equation (2) may be used.
LOQ

ng arsenic
g formula

mg formula
cartridge
 1 cartridge
day
 1 g
1000 mg
 100% transfer ¼ ng arsenic
day
(2)
Such that,
430 ng arsenic
g formula
 420 mg formula
cartridge
 1 cartridge
day
 1 g
1000 mg
 100% transfer ¼ 181 ng arsenic
day
Unpublished data show that an average MarkTen® user con-
sumes one cartridge per day, which contains 420 mg formula.
Assuming this daily consumption and that 100% of the arsenic
transfers to aerosol, an average user may be exposed to a maximum
of 430 ng (the method LOQ) arsenic per gram formula (181 ng
arsenic per day). This estimated daily exposure is more than 500
fold lower than the equivalent daily exposure derived from expo-
sure to arsenic at the TWA.
Similarly, Equation (3) is used to convert the exposure concen-
tration to an equivalent daily exposure that is associated with a
cancer risk of 106 or for chronic exposure non-cancer effects (RfC).
Using toluene, a non-carcinogenic neurotoxicant as an example,
with an EPA RfC of 5 mg/m3 (EPA, 2005) the equivalent daily
exposure derived from the exposure to toluene at the RfC may be
calculated as follows:
exposure concentration

mg
m3

 daily inhalation rate

m3
day

¼ estimated daily exposure

mg
day

(3)
5 mg
m3
 28:8 m
3
day
¼ 144 mg
day
Because toluene is measured on a per device basis and its LOD is
1.7 mg/device, the total daily exposure to toluene of an average
MarkTen® e-cigarette user is estimated to be less than 1.7 mg/day
(the LOD) on a daily basis. This exposure estimate is more than
80,000 times less than the equivalent daily exposure derived from
exposure to toluene at the EPA RfC.3. Results and discussion
Table 7 shows the chemical classes, analytes, range of average
triplicate results, LOQs, and units reported for the e-cigarette for-
mulations evaluated in this study. Because one of the objectives of
this research was to conduct a risk assessment analysis of the e-
liquid formulation impurities and aerosol chemicals detected, cal-
culations were performed on all LODs (or LOQs if LODs were not
available) to ensure that the methods could detect analytes at
concentrations relevant for this risk assessment.
Because all the risk values are based on average daily expo-
sures, average daily MarkTen® e-cigarette consumption must be
estimated. However, although e-cigarette use is gainingpopularity, it is still a dynamic market, and data on consumption
patterns are not robust. Some investigators have used retrospec-
tive online survey tools to determine e-cigarette use in puffs per
day (Etter, 2010; Etter and Bullen, 2014). Puffs per day may be a
difﬁcult parameter for e-vapor product users to remember and
quantify. These surveys may also fail to categorize whether the
user is using a cartridge based product such as MarkTen® or an
open or tank system. The patterns of use may differ substantially
within the overall e-vapor category. Other investigators have re-
ported mean cartridge or cartridge use per day of approximately 1
cartridge/day (Caponnetto et al., 2013; Farsalinos and Polosa,
2014) or 3 cartridges over a 7-day period (Wagener et al., 2014).
These estimates of cartridge use per day closely mirror the man-
ufacturer's unpublished data on MarkTen® e-cigarette consump-
tion, so an assumption of one cartridge per day is considered to be
the daily consumption rate.
EPA reports the de minimus risk level (at 106) for exposures to
arsenic (2  104 mg/m3) and cadmium (6  104 mg/m3) as well as
a RfC for ammonia (0.1 mg/m3) (EPA, 1998c, 2003c, 2003e). OEHHA
(2013) reports NSRLs for arsenic (0.06 mg/day), cadmium (0.05 mg/
day), NNK (0.014 mg/day), and NNN (0.5 mg/day). ACGIH reports
limits for arsenic (0.01 mg/m3), while OSHA reports a permissible
exposure limit (PEL) of 0.005 mg/m3 for cadmium (ACGIH, 2015).
Using the risk assessment procedure described in Section 2.4, the
LODs for NNK, NNN and ammonia are sufﬁcient with which to
conduct quantitative risk assessments. The LODs are low enough to
detect the presence of these constituents at levels that regulatory
bodies consider to be relevant to human exposure. Assuming that
100% of each chemical from the liquid transfers to the aerosol and
that the liquid contains the analyte at its LOD/LOQ, the daily
exposure to each of these three analytes is well below the OEHHA
NSRL (NNN and NNK) or the EPA RfC (ammonia). The analytical
methods are not sufﬁciently sensitive to detect such low levels of
arsenic and cadmium at EPA de minimus and OEHHA risk levels for
some metals in e-liquid formulations, but the methods are sufﬁ-
ciently sensitive to show that the potential daily exposures to these
metals fall below the calculated daily exposures derived from the
ACGIH TLV (arsenic) and the OSHA PEL (cadmium). It is also un-
likely that the metals will transfer with 100% efﬁciency from the e-
liquid formulation to the aerosol. Nonetheless, additional work
should be undertaken to improve the sensitivity of the metal
analyses.
For the nicotine-related impurities of which risk assessment
values were not available, the ICH guideline “Impurities in New
Drug Products” Q3B(R2) was employed (ICH, 2006). The guideline
describes three thresholds. First, the reporting threshold is a “limit
above which a degradation product should be reported” (ICH,
2006). Next, the identiﬁcation threshold is a “limit above which a
degradation product should be identiﬁed” (ICH, 2006). Lastly, the
qualiﬁcation threshold is a “limit above which a degradation
product should be qualiﬁed” where qualiﬁcation involves a “pro-
cess of acquiring and evaluating data that establishes the biological
safety of an individual degradation product” (ICH, 2006). While
NNNwas not detectable, NNK was below the LOQ in the e-cigarette
formulations investigated in this study (Table 7). The LOQ levels are
less than 0.002% of the total nicotine concentration (based upon
total nicotine concentration). While the e-cigarettes in this study
are not pharmaceutical products, these values would be within
acceptable limits for unspeciﬁed impurities in pharmaceutical
grade nicotine. The LOQ for NNK is well below the reporting
thresholds proposed in the ICH guideline Q3B(R2) for a maximum
daily dose of 1 g or less of nicotine (reporting threshold ¼ 0.1%)
(ICH, 2006).
Nicotine-related impurities speciﬁed in the European Pharma-
copeia were both below LOQ and within quantiﬁable ranges of the
Table 7
Range of average results and limits of quantitation for e-cigarette formulation analysis.
Chemical class Analyte Range of average results (N ¼ 3) LOQ Units
Metals Arsenic ND 430 ng/g
Cadmium ND 220 ng/g
Tobacco speciﬁc nitrosamines NNK NDeBLOQ 90 ng/g
NNN ND 90 ng/g
Ammonia Ammonia ND 40 mg/g
Nicotine-related impurities Nicotine-N-oxides 11e19 4.8 mg/g
Cotinine BLOQe9.4 4.8 mg/g
Nornicotine 14e31 4.8 mg/g
Anatabine NDeBLOQ 4.8 mg/g
Myosmine 7.4e13 4.8 mg/g
Anabasine BLOQ 4.8 mg/g
b-Nicotyrine BLOQ 4.8 mg/g
BLOQ, below the limit of quantitation; ND, not detected; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; NNN, N-nitrosonornicotine.
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speciﬁed nicotine impurities were less than 0.3% of the nicotine
concentration. Therefore, the speciﬁed impurities levels were well
below the identiﬁcation and qualiﬁcation thresholds proposed in
the ICH guideline Q3B(R2) for maximum daily dose of 1 mge10mg,
respectively (ICH, 2006).
As shown in Table 8, most potentially harmful chemicals in the
MarkTen® e-cigarette aerosols were not detectable using 4-s puff
duration, 55-mL puff volume, and square wave puff proﬁle. Under
these pufﬁng conditions, the average aerosol nicotine concentra-
tionwas 29 mg/puff. Calculations were performed on all LODs (LOQs
were used when LODs were not available) for the potential impu-
rities and degradation products to ensure that the methods could
measure the analytes in appropriate concentrations for our risk
assessments. No exposure threshold information was available for
1-aminonaphthalene or 2-aminonaphthalene. Carcinogenic inha-
lation concentrations at 106 as deﬁned by EPA were available for
acetaldehyde (0.5 mg/m3), formaldehyde (0.08 mg/m3), acrylonitrile
(0.01 mg/m3), benzene (0.13 mg/m3), 1,3-butadiene (0.002 mg/m3),
arsenic (0.0002 mg/m3), and cadmium (0.0006 mg/m3) (EPA, 1998a,
1998b, 1998c, 2002, 2003a, 2003b, 2003c). EPA also reports RfCs for
toluene (5 mg/m3), 1,3-butadiene (0.03 mg/m3), benzene (0.03 mg/
m3), acrylonitrile (0.002 mg/m3), acrolein (0.00002 mg/m3), acet-
aldehyde (0.009 mg/m3), and ammonia (0.1 mg/m3) (EPA, 1998b,
2002, 2003a, 2003b, 2003d, 2003e, 2005). OSHA PELs were avail-
able for acetaldehyde (360 mg/m3), acrolein (0.25 mg/m3),Table 8
Range of average results and limits of quantitation for e-cigarette aerosol analysis.
Chemical class Analyte Ra
Carbonyls Acetaldehyde BL
Acrolein ND
Crotonaldehyde ND
Formaldehyde 0.0
Aromatic amines 4-Aminobiphenyl ND
1-Aminonaphthalene ND
2-Aminonaphthalene ND
Volatile organic compounds Acrylonitrile ND
Benzene ND
1,3-Butadiene ND
Isoprene ND
Toluene ND
Tobacco speciﬁc nitrosamines NNK BL
NNN BL
Ammonia Ammonia BL
Polyaromatic hydrocarbons Benzo[a]pyrene ND
Carbon monoxide Carbon monoxide ND
BLOQ, below the limit of quantitation; LOQ, limit of quantitation; ND ¼ not detected; N
a 20 puffs per collection.
b 50 puffs per collection.crotonaldehyde (6 mg/m3), 1,3-butadiene (2.2 mg/m3), and cad-
mium (0.005 mg/m3) (OSHA, 2003). ACGIH TLVs were available for
benzene (1.6 mg/m3), toluene (75 mg/m3), CO (29 mg/m3), and
arsenic (0.01 mg/m3) (ACGIH, 2015). Additionally, DFG reports
occupational exposure limits for formaldehyde (0.37 mg/m3),
isoprene (85 mg/m3), and ammonia (14 mg/m3), while the National
Institute of Occupational Safety and Health (NIOSH) issued a rec-
ommended exposure limit for B[a]P of 0.1 mg/m3 (ACGIH, 2015).
OEHHA (2013) has also published NSRLs for acetaldehyde (90 mg/
day), formaldehyde (40 mg/day), 4-aminobiphenyl (0.03 mg/day),
acrylonitrile (0.07 mg/day), benzene (13 mg/day), 1,3-butadiene
(0.4 mg/day), toluene (13,000 mg/day), NNK (0.014 mg/day), NNN
(0.5 mg/day), B[a]P (0.06 mg/day), arsenic (0.06 mg/day), and cad-
mium (0.05 mg/day) (Table 6). All LODs (LOQs where LODs were not
available) were sufﬁcient to perform a risk assessment as described
in Section 2.4, compare with occupational exposure limits, and
demonstrate that the potential daily exposure to each analyte is
below published occupational exposure limits for each chemical.
Additionally, with the exception of acrolein, the LODs (or LOQs)
were sufﬁciently low to facilitate the comparison of exposure from
MarkTen® e-cigarettes to published RfCs. Although acroleinwas not
detected in the aerosol from MarkTen® e-cigarettes, and the LOD is
sufﬁcient to demonstrate that acrolein exposure is below occupa-
tional exposure standards, additional efforts to lower the LOD of
acrolein in aerosol should be made to demonstrate that potential
exposure is also below the RfC.nge of average results (N ¼ 3) LOQ Units
OQ 0.71 mg/puffa
0.36 mg/puffa
0.19 mg/puffa
90 to 0.33 0.036 mg/puffa
0.50 ng/device
2.0 ng/device
1.0 ng/device
5.0 mg/device
10 mg/device
10 mg/device
50 mg/device
20 mg/device
OQ 40 ng/device
OQ 40 ng/device
OQ 10 mg/device
10 ng/device
5.0 mg/deviceb
NK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; NNN, N-nitrosonornicotine.
Fig. 1. Summarized mechanism for the (oxy)dehydration of glycerol (Deleplanque
et al., 2010).
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comparison to published occupational exposure limits, are not
sufﬁcient for comparison to EPA risk assessment values or OEHHA
NSRLs. Neither of these compounds was detected in MarkTen® e-
cigarette aerosol, however, opportunities to increase the sensitivity
of these methods should be taken. With the exception of formal-
dehyde, the LODs of other compounds measured in aerosol are
sufﬁcient for comparison with the EPA risk assessment values and
the NSRLs.
Formaldehyde was detected at low levels in all devices and
ranged from 1.8 to 6.5 mg/20-puff collection using the pufﬁng pa-
rameters listed in Table 5. These levels can be estimated to average
approximately 0.090e0.33 mg formaldehyde/puff (Table 8). The
calculated potential daily exposure to formaldehyde resulting from
this per-puff concentration range is approximately 2e5 times lower
than the equivalent daily exposure derived from exposure to
formaldehyde at the limit established by DFG. The NSRL for form-
aldehyde, however, is 40 mg/day. Assuming that one MarkTen®
cartridge provides 80 puffs and that each puff contains 0.33 mg
formaldehyde, the estimated daily exposure to formaldehyde is
about 26 mg/day, which is less than the NSRL of 40 mg/day. This
estimated exposure value is, however, more than 10 times the
equivalent daily exposure derived from exposure to formaldehyde
at the 106 risk value as deﬁned by IRIS (2.3 mg/day; 0.08 mg/m3
multiplied by 28.8 m3/day).
Detection of low levels of carbonyl compounds in e-cigarette
aerosols has been previously observed for commercial e-cigarette
products (Goniewicz et al., 2014; Uchiyama et al., 2013; Lauterbach
and Laugesen, 2012). In the study by Uchiyama et al. (2013), 9 of the
13 products tested showed detectable levels of carbonyls at variable
levels. Goniewicz et al. (2014) reported that, of the 15 e-cigarettes
in their study, formaldehyde and acetaldehyde were found in
aerosols from all tested products, and acrolein was found in all but
one. Goniewicz et al. (2014) also detected formaldehyde inTable 9
Standardized tobacco smoking regimes and e-cigarette pufﬁng regime used in this study
Condition Puff volume (mL) Duration (s)
ISO (conventional cigarettes) 35 2
MDPH (conventional cigarettes) 45 2
HCI (conventional cigarettes) 55 2
This study (e-cigarettes) 55 4
HCI, Health Canada Intense; ISO, International Organization for Standardization; MDPH,medicinal inhalers “at levels that overlapped with those found in e-
cigarette vapour.” While formaldehyde is a Group I carcinogen ac-
cording to the International Agency for Research on Cancer (IARC,
2006), it is also ubiquitous. The World Health Organization
(WHO) estimates that the daily human exposure to formaldehyde
from breathing is between 1 and 8 mg/day. These exposures result
from formaldehyde in outside air as well as from homes and
workspaces. WHO (2001) estimates that the formaldehyde expo-
sure from a conventional home is 300e600 mg/day. Additionally,
formaldehyde is a by-product of metabolic processes and is
detectable in exhaled breath. The Agency for Toxic Substances and
Disease Registry found that the median detected level of formal-
dehyde in breath is 4.263 ppb (ATSDR, 2010). Assuming a daily
breath volume of 20 m3/day, the average adult exhales 106 mg/day.
This estimate is well above the NSRL of 40 mg/day and the IRIS
cancer risk value of 2.3 mg/day. Based on the potential exposure to
formaldehyde from sitting indoors or from exposure to human
exhalate, the data suggest that the risk values reported by OEHHA
and EPA are unattainable and may be overly conservative.
It is important to consider that pufﬁng parameters and tem-
perature of the e-cigarette heater coil can play a role in measured
carbonyl levels. Kosmider et al. (2014) recently demonstrated that
increasing the voltage of select commercially available reﬁllable
devices resulted in a 4- to 200-fold increase in select carbonyls.
Therefore, under less-intense pufﬁng parameters, carbonyl levels
may be lower, and under more-intense parameters they may be
higher. The mechanism for carbonyl formation has been previously
discussed, and it was shown that glycerol and glycols can form
carbonyls upon thermal degradation (Deleplanque et al., 2010;
Kosmider et al., 2014; Laino et al., 2011; Paine III et al., 2007;
Uchiyama et al., 2013).The mechanism is summarized for glycerol
in Fig. 1.
It is difﬁcult to compare reported concentrations of potentially
harmful e-cigarette aerosol chemicals (e.g., carbonyls) across
currently available e-cigarette studies because the pufﬁng regimes
are very different from study to study. Goniewicz et al. (2014) used
a 1.8-s puff, 70-mL puff volume, and 10-s interval between puffs. In
the study by Uchiyama et al. (2013), a 2-s puff, 55-mL puff volume,
and 30-s interval, was used (Table 5). In this current study, a 4-
s puff, 55-mL volume, and 30-s interval was used. Clearly, a
consensus of appropriate pufﬁng regimes for e-cigarette analysis is
needed to best compare e-cigarette models. The CORESTA E-ciga-
rette Task Force was recently formed to address this and other
important e-cigarette issues. The pufﬁng proﬁle used in our study
was selected based upon the following: it was a pufﬁng regime
being evaluated by the CORESTA task force at the time of this study;
it was the maximum puff duration that the smoking machines
could collect for carbonyl analysis (5-port linear KC Automation
smoking machine with dual impingers); and it reﬂected observa-
tions of the average pufﬁng topography of experienced e-cigarette
users to the best of our knowledge at this time (Vansickel et al.,
2014).
As stated by Goniewicz et al. (2014) and consistent with our
observations, the levels of potentially harmful chemicals found in
e-cigarette models are far less than those observed in conventional.
Approximate puff count Interval (s) Ventilation blocking (%)
5e10 60 0
8e15 30 50
6e14 30 100
Up to battery exhaustion 30 NA
Massachusetts Department of Public Health; NA, not applicable.
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difﬁcult to make a direct comparison between e-cigarette and
conventional cigarette constituent yields because the pufﬁng re-
gimes are very different. Conventional cigarettes are typically
tested under standardized conditions referred to as ISO, Massa-
chusetts Department of Public Health (MDPH), and/or HCI condi-
tions. Table 9 shows the differences in the puff volumes, puff
durations, approximate puff count (for conventional cigarettes this
depends on factors such rod length and ﬁller density), intervals, and
ventilation blocking percentage. It should be noted that machine
smoking regimes for both conventional tobacco cigarettes and e-
cigarettes are for product comparison purposes only and do not
represent individual human exposure or how the tobacco product
is actually used. It is well known that consumers of both conven-
tional tobacco cigarettes and e-cigarettes vary greatly in how they
use these products.
As shown in Table 8, TSNAs (NNN and NNK) were below the
limit of quantitation (BLOQ) in the e-cigarette aerosols collected
under the pufﬁng parameters shown in Table 9. This, too, has been
previously observed, and it was concluded that the levels found in
e-cigarette models were far lower than those found in tobacco
smoke (Goniewicz et al., 2014). Furthermore, these levels are well
within acceptable limits for pharmaceutical grade nicotine (Council
of Europe, 2012).
Ammonia was also BLOQ in the e-cigarette aerosols collected
under the pufﬁng parameters shown in Table 9 (the LOQ is 10 mg/
device). It is well known that during protein metabolism in mam-
mals, the urea cycle produces endogenous ammonia which is
eliminated via the liver and the kidney. OSHA has established a PEL
for inhaled ammonia in the workplace of approximately 167 mg/
day (ACGIH, 2015). The LOQ for the ammonia method, based on the
assumption discussed in Section 2.4, is more than 8000 times lower
than the OSHA PEL.4. Conclusions
Most potential impurities investigated in this study were not
detectable or were well below LOQs in the commercially available
MarkTen® e-cigarettes analyzed. The levels of potential e-liquid
formulation impurities and potentially harmful chemicals detected
in the aerosol were determined to be below published occupational
exposure limits using the aerosol collection regime discussed
herein. More- or less-aggressive pufﬁng parameters for e-cigarette
aerosol collections however, may result in higher or lower levels of
potentially harmful chemicals in the aerosol.
While this research is not a comprehensive survey of commer-
cially available products, it does demonstrate that many of the
HPHCs evaluated in conventional tobacco cigarettes (FDA, 2012b)
may not be applicable to measure in e-cigarette formulations and
aerosols. However, the constituents that were observed in this
study might provide insights regarding potential impurities likely
to be further investigated with other products in this emerging
product category. This work also demonstrates the urgent need for
a standardized pufﬁng regime for e-vapor products in order to
make reasonable comparisons among studies. It is also imperative
that standardized analytical testing methodologies be established
for e-cigarettes in order to reduce analytical variability and maxi-
mize sensitivity for reported values of potential impurities in these
products. A comprehensive survey of commercially available e-
cigarettes would then be of value to the scientiﬁc community and
regulators; however, this, too, is a challenging endeavor as these
unregulated products are often changing, and new product forms
frequently emerge in the marketplace.Acknowledgments
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